Joseph AlvarÂnas, MD, direcÂtor of value-based analytics at City of Hope, Duarte, California, and editor-in-chief of Evidence-Based Oncology painted an upbeat picture of cancer cure rates at the 2015 meeting of Patient-Centered Oncology Care.
Joseph Alvar­nas, MD, direc­tor of value-based analytics at City of Hope, Duarte, California, and editor-in-chief of Evidence-Based Oncology painted an upbeat picture of cancer cure rates at the 2015 meeting of Patient-Centered Oncology Care.
During his session, Dr Alvarnas outlined the rapid changes in medicine and the profound impact the development of targeted immunotherapy agents have had on patient outcomes. Here are the slides from his session, slightly modified.
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More